tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunome’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating
PremiumRatingsImmunome’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating
17d ago
Immunome reports Q2 EPS (50c), consensus (50c)
Premium
The Fly
Immunome reports Q2 EPS (50c), consensus (50c)
17d ago
Immunome Elects New Directors at Annual Meeting
Premium
Company Announcements
Immunome Elects New Directors at Annual Meeting
2M ago
Immunome reports Q1 EPS (52c), consensus (57c)
PremiumThe FlyImmunome reports Q1 EPS (52c), consensus (57c)
3M ago
Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’
Premium
The Fly
Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’
4M ago
Immunome initiated with a Buy at Lake Street
Premium
The Fly
Immunome initiated with a Buy at Lake Street
5M ago
Immunome’s Promising Pipeline and Strategic Acquisition Drive Buy Rating
PremiumRatingsImmunome’s Promising Pipeline and Strategic Acquisition Drive Buy Rating
5M ago
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
Premium
Ratings
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
5M ago
Immunome’s 2024 Financial Results and Pipeline Progress
Premium
Company Announcements
Immunome’s 2024 Financial Results and Pipeline Progress
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100